Equities

TheraCryf PLC

TCF:LSE

TheraCryf PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.85
  • Today's Change0.00 / 0.00%
  • Shares traded12.39k
  • 1 Year change-72.13%
  • Beta1.5751
Data delayed at least 20 minutes, as of Jul 05 2024 10:56 BST.
More ▼
DateOpenHighLowCloseVolume
Friday, July 05, 2024Fri, Jul 05, 20240.850.8010.8010.8512,39312.39k
Thursday, July 04, 2024Thu, Jul 04, 20240.850.8010.800.8512,77612.78k
Wednesday, July 03, 2024Wed, Jul 03, 20240.850.87250.800.85102,455102.46k
Tuesday, July 02, 2024Tue, Jul 02, 20240.850.820.8010.85510,000510.00k
Monday, July 01, 2024Mon, Jul 01, 20240.850.850.850.8500.00
Friday, June 28, 2024Fri, Jun 28, 20240.850.89350.800.85217,618217.62k
Thursday, June 27, 2024Thu, Jun 27, 20240.850.8750.800.8596,59896.60k
Wednesday, June 26, 2024Wed, Jun 26, 20240.850.820.800.85591,834591.83k
Tuesday, June 25, 2024Tue, Jun 25, 20240.850.89350.89350.85560560.00
Monday, June 24, 2024Mon, Jun 24, 20240.8750.89350.800.85409,701409.70k
Friday, June 21, 2024Fri, Jun 21, 20240.9250.91750.820.8751,500,4991.50m
Thursday, June 20, 2024Thu, Jun 20, 20240.9750.92750.900.9251,756,7511.76m
Wednesday, June 19, 2024Wed, Jun 19, 20240.9750.9750.9250.975611,240611.24k
Tuesday, June 18, 2024Tue, Jun 18, 20240.9750.980.980.975250,000250.00k
Monday, June 17, 2024Mon, Jun 17, 20240.9750.9850.900.975101,998102.00k
Friday, June 14, 2024Fri, Jun 14, 20241.001.050.900.9752,485,5022.49m
Thursday, June 13, 2024Thu, Jun 13, 20240.951.000.901.009,045,9869.05m
Wednesday, June 12, 2024Wed, Jun 12, 20240.9251.000.860.9511,970,84211.97m
Tuesday, June 11, 2024Tue, Jun 11, 20240.901.000.850.9252,743,2662.74m
Monday, June 10, 2024Mon, Jun 10, 20240.900.9940.800.9025,59825.60k
Friday, June 07, 2024Fri, Jun 07, 20240.851.000.800.901,554,5771.55m
Data delayed at least 20 minutes, as of Jul 05 2024 11:56 BST.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.